Management of Osteoporosis in Patients with Multiple Non-Traumatic Fractures

Diagnostic Evaluation

The American College of Rheumatology recommends immediate comprehensive fracture risk evaluation, including DXA scanning, vertebral imaging, and laboratory workup for secondary osteoporosis, in patients with multiple non-traumatic fractures 1, 2
Essential laboratory assessment includes serum calcium, albumin, creatinine, thyroid-stimulating hormone, and erythrocyte sedimentation rate to identify secondary causes of osteoporosis 3
DXA scanning of lumbar spine and hip is necessary to quantify bone mineral density and establish baseline T-scores 4, 3
Spinal imaging, such as radiography or vertebral fracture assessment, is recommended to detect subclinical vertebral fractures 3

The American College of Rheumatology recommends alendronate or risedronate as first-line therapy for osteoporosis, which reduces vertebral fractures by 47-48%, non-vertebral fractures by 26-53%, and hip fractures by 51% 1, 4
Bisphosphonates should be prescribed for 3-5 years initially, with longer duration if high fracture risk persists 1, 5
Alternative pharmacological options, such as zoledronic acid or denosumab, may be considered in cases of oral intolerance, malabsorption, or non-compliance 1, 6

Vitamin D supplementation of 800 IU daily is recommended, as it reduces non-vertebral fractures by 15-20% and falls by 20% 1, 6, 5
Calcium supplementation of 1000-1200 mg daily is necessary when using anti-osteoporosis drugs 6, 7
Lifestyle modifications, such as smoking cessation and alcohol limitation, are essential to improve bone mineral density and reduce fall risk 6, 7

A structured collaboration between healthcare providers is essential for managing patients with osteoporosis, and a designated coordinator should oversee the five-step plan: identification, fracture risk evaluation, differential diagnosis, therapy initiation, and systematic follow-up 1, 4
Regular monitoring for medication tolerance and adherence is crucial, as adherence rates reach 90% with structured follow-up versus poor adherence without it 1, 4